Hospira Recalls Sterile Water for Injection Due to Sterility Concerns
Hospira is recalling 153,504 bags of Sterile Water for Injection due to potential punctures that may compromise sterility and cause leaks.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable product, which poses a significant risk of serious injury.
Plain-English summary
Hospira Inc. is recalling 153,504 bags of Sterile Water for Injection, USP, 1000 mL container (NDC 0409-7990-09). The recall is due to a lack of assurance of sterility, specifically the potential for punctures through the overwrap and primary container which may result in IV bag leaks.
The affected product is identified by Lot# 36-084-JT with an expiration date of 12/15. The product was distributed nationwide, as well as in Puerto Rico and the U.S. Virgin Islands.
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or the manufacturer for further instructions.
The recalled product
- Product
- Sterile Water for Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7990-09.
- Manufacturer
- Hospira Inc.
- Category
- Drug — Injectable
- Affected units
- 153,504
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 36-084-JT
- Exp.12/15
Distribution
Part of a larger recall action
This product is one of 11 recalled by Hospira Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 11 products in this recall →Related recalls
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recalled for White Screen Shutdown
FDA (Devices) · 2016-11-16
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SeverePfizer Recalls Sterile Water for Injection Vials Due to Cracked Glass
FDA (Drugs) · 2017-10-04
- SevereHospira Recalls 70% Dextrose Injection Due to Possible Leaking Bags
FDA (Drugs) · 2013-07-03
- HighHospira Recalls Sodium Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-03
- SevereHospira Recalls 5% Dextrose Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-03
- SevereHospira Recalls 0.9% Sodium Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-03-13
- SevereHospira Recalls 20% Dextrose Injection Due to Possible Leaking Bags
FDA (Drugs) · 2013-07-03